Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Neuropsychopharmacol Rep. 2024 Sep;44(3):569-571. doi: 10.1002/npr2.12463. Epub 2024 Jun 25.
The incidence of major depressive disorder (MDD) after heart transplantation is high; however, there are no reports on treatment options when antidepressant therapy fails to improve the condition. We herein report on the case of a woman with MDD after heart transplantation who partially improved with antidepressant treatment but continued to have a loss of appetite. Augmentation treatment with aripiprazole improved her appetite, and her MDD went into remission. When antidepressant treatment is not sufficiently effective for MDD after heart transplantation, augmentation treatment with antipsychotics, such as aripiprazole, should be considered.
心脏移植后重度抑郁症(MDD)的发病率很高;然而,当抗抑郁治疗未能改善病情时,尚无关于治疗选择的报道。本文报告了一例心脏移植后 MDD 患者,她的抗抑郁治疗部分改善,但仍持续食欲不振。阿立哌唑增效治疗改善了她的食欲,她的 MDD 缓解了。当心脏移植后 MDD 的抗抑郁治疗效果不充分时,应考虑使用阿立哌唑等抗精神病药增效治疗。